CNS Pharmaceuticals had a revenue of 0.00 in the quarter ending Sep 30, 2025, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Mar 31, 2025, CNS Pharmaceuticals had annual revenue of 0.00 with ― growth.